Contact Us
Home
Company
Leadership
Board of Directors
Medical Advisory Board
Careers
Products
EsoCheck
EsoGuard
Investor Relations
Contact
Home
Company
Leadership
Board of Directors
Medical Advisory Board
Careers
Products
EsoCheck
EsoGuard
Investor Relations
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
NASDAQ: PAVM
NASDAQ: PAVMZ
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
CERT
CERTNAS
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEL AM
DRS
DRS/A
DRSLTR
EFFECT
FWP
NT 10-K
NT 10-Q
PRE 14A
PRE 14C
RW
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-4
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
UPLOAD
Year:
View All
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Date
Form
Description
PDF
XBRL
Pages
02/23/22
4
Statement of changes in beneficial ownership of securities
2
02/23/22
4
Statement of changes in beneficial ownership of securities
1
02/23/22
4
Statement of changes in beneficial ownership of securities
2
02/18/22
4
Statement of changes in beneficial ownership of securities
1
02/18/22
3
Initial statement of beneficial ownership of securities
1
02/15/22
8-K
Current report filing
Documents
EX-99.1
3
02/04/22
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
01/28/22
25-NSE
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Documents
EX-99.25
2
01/10/22
424B5
Prospectus filed pursuant to Rule 424(b)(5)
26
01/07/22
EFFECT
Notice of Effectiveness
1
Previous
1…
3
4
5
6
7
8
9
10
11
12
…52
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed